Mezenkimal kök hücrelerin greft enfeksiyonlarında antibakteriyel etkisi: Deneysel bir çalışma
Amaç: Bu çalışmada, sıçan modelinde, tigesikline kıyasla, mezenkimal kök hücrelerin metisiline dirençli Staphylococcus epidermidis ile ilişkili greft enfeksiyonu üzerindeki antibakteriyel etkileri araştırıldı. Çalışma planı: Toplam 42 erkek erişkin Wistar cinsi sıçan (yaş >6 ay; ağırlık 300-350 g) her grupta yedi sıçan olacak şekilde altı gruba ayrıldı. Grup 0 herhangi bir prosedürden geçmedi; Grup 1 enfekte edildi, ancak tedavi edilmedi; Grup 2 enfekte edildi ve greft yerleştirilmeden tigesiklin ile tedavi edildi; Grup 3 enfekte edildi ve greft yerleştirilmeden mezenkimal kök hücre ile tedavi edildi; Grup 4 greft yerleştirildikten sonra enfekte edildi ve tigesiklin ile tedavi edildi; Grup 5 greft yerleştirildikten sonra enfekte edildi ve mezenkimal kök hücre ile tedavi edildi. Oluşturulan cepler boş bırakıldı veya Dacron greftle implante edildi. Tedaviye 48 saat sonra başlandı. Numuneler 13. günde toplandı. Perigreft dokular histopatolojik olarak değerlendirildi ve bakteri koloni sayıları tespit edildi. Bulgular: Grup 0'da bakteri kolonizasyonu gözlenmez iken, Grup 1'de belirgin kolonizasyon görüldü. Grup 2 ve Grup 3'te (greftsiz gruplar) tam eradikasyon sağlandı ve Grup 4 ve Grup 5'te (greft yerleştirilen gruplar) tama yakın eradikasyon elde edildi. Histopatolojik bulgular açısından Grup 1-Grup 2 ve Grup 1-Grup 3 arasında (greftsiz gruplar) anlamlı bir fark vardı. Histopatolojik bulgular Grup 2-Grup 3 ve Grup 4-Grup 5 arasında benzerdi. Sonuç: Çalışma sonuçlarımız, mezenkimal kök hücrelerin antibiyotik tedavisine yeni ve modern bir alternatif olabileceğini ve enfekte greft alanlarında Staphylococcus’un biyoyükünü azaltabileceğini ve mezenkimal kök hücre tedavisinin tigesiklin kadar etkili olabileceğini göstermektedir.
The antibacterial effect of mesenchymal stem cells on graft infections: An experimental study
Background: In this study, we aimed to investigate the antibacterialeffects of mesenchymal stem cells, compared to tigecycline, on graftinfection related with methicillin-resistant Staphylococcus epidermidisin a rat model.Methods: A total of 42 male adult Wistar rats (age >6 months; weight300 to 350 g) were divided into six groups including seven rats in each.Group 0 did not undergo any procedure; Group 1 was infected, butuntreated; Group 2 was infected and treated with tigecycline withoutgraft placement; Group 3 was infected and received mesenchymal stemcells without graft placement; Group 4 was infected and treated withtigecycline after graft placement; Group 5 was infected and treatedwith mesenchymal stem cells after graft placement. The pocketscreated were either left empty or implanted with Dacron grafts.Treatment was commenced at 48 h. Specimens were collected on Day13. Perigraft tissues were evaluated histopathologically and bacterialcolony numbers were counted.Results: No bacterial colonization was observed in Group 0, whereasthere was a significant colonization in Group 1. Complete eradicationwas achieved in Group 2 and Group 3 (graft-free groups), andnear-complete eradication was achieved in Group 4 and Group 5(graft-implanted groups). The histopathological findings significantlydiffered between Group 1-Group 2 and between Group 1-Group3 (graft-free groups). The histopathological findings were similarbetween Group 2-Group 3 and between Group 4-Group 5.Conclusion: Our study results suggest that mesenchymal stem cellsmay be a novel, contemporary alternative to antibiotherapy and maydecrease the bio-burden of Staphylococcus at the infected graftareas, and mesenchymal stem cell treatment may be as effective astigecycline.
___
- Yang SY, Strong N, Gong X, Heggeness MH. Differentiation
of nerve-derived adult pluripotent stem cells into osteoblastic
and endothelial cells. Spine J 2017;17:277-81.
- Bakre MM, Hoi A, Mong JC, Koh YY, Wong KY, Stanton
LW. Generation of multipotential mesendodermal progenitors
from mouse embryonic stem cells via sustained Wnt pathway
activation. Biol Chem 2007;282:31703-12.
- Alcayaga-Miranda F, Cuenca J, Martin A, Contreras L,
Figueroa FE, Khoury M, et al. Combination therapy of
menstrual derived mesenchymal stem cells and antibiotics
ameliorates survival in sepsis. Stem Cell Res Ther 2015;6:199.
- Ma S, Xie N, Li W, Yuan B, Shi Y, Wang Y.
Immunobiology of mesenchymal stem cells. Cell Death
Differ 2014;21:216-25.
- Sutton MT, Fletcher D, Ghosh SK, Weinberg A, van
Heeckeren R, Kaur S, et al. Antimicrobial Properties
of Mesenchymal Stem Cells: Therapeutic Potential for
Cystic Fibrosis Infection, and Treatment. Stem Cells Int
2016;2016:5303048.
- Sung DK, Chang YS, Sung SI, Yoo HS, Ahn SY, Park WS.
Antibacterial effect of mesenchymal stem cells against
Escherichia coli is mediated by secretion of beta- defensin2
via toll- like receptor 4 signalling. Cell Microbiol.
2016;18:424-36.
- Murphy K, Weaver C. Janeway's immunobiology. 9th ed.
New York: Garland Science 2016.
- Revest M, Camou F, Senneville E, Caillon J, Laurent F,
Calvet B, et al. Medical treatment of prosthetic vascular
graft infections: Review of the literature and proposals of a
Working Group. Int J Antimicrob Agents 2015;46:254-65.
- Romanò CL, Manzi G, Logoluso N, Romanò D. Value of
debridement and irrigation for the treatment of peri-prosthetic
infections. A systematic review. Hip Int 2012;22:19-24.
- Gardete S, Tomasz A. Mechanisms of vancomycin resistance
in Staphylococcus aureus. J Clin Invest 2014;124:2836-40.
- Yasim A, Gul M, Ciralik H, Ergun Y. Gelatin-sealed dacron
graft is not more susceptible to MRSA infection than PTFE
graft. Eur J Vasc Endovasc Surg 2006;32:425-30.
- Aybar Y, Ozaras R, Besirli K, Engin E, Karabulut E,
Salihoglu T, et al. Efficacy of tigecycline and vancomycin
in experimental catheter-related Staphylococcus epidermidis
infection: microbiological and electron microscopic analysis
of biofilm. Int J Antimicrob Agents 2012;39:338-42.
- Drew WL, Barry AL, O’Toole R, Sherris JC. Reliability
of the Kirby-Bauer disc diffusion method for detecting
methicillin-resistant strains of Staphylococcus aureus. Appl
Microbiol 1972;24:240-7.
- Goessens WH, Mouton JW, Ten Kate MT, Sörgel F,
Kinzig M, Bakker-Woudenberg IA. The therapeutic
effect of tigecycline, unlike that of Ceftazidime, is not
influenced by whether the Klebsiella pneumoniae strain
produces extended-spectrum b-lactamases in experimental
pneumonia in rats. Antimicrob Agents Chemother
2013;57:643-6.
- Nagaya N, Kangawa K, Itoh T, Iwase T, Murakami S,
Miyahara Y, e.t al. Transplantation of mesenchymal stem
cells improves cardiac function in a rat model of dilated
cardiomyopathy. Circulation 2005;112:1128-35.
- Ozturk B, Kurtoglu T, Durmaz S, Kozaci LD, Abacigil F,
Ertugrul B, et al. The effects of ozone on bacterial growth
and thiol-disulphide homeostasis in vascular graft infection
caused by MRSA in rats. Acta Cir Bras 2017;32:219-28.
- Hernández-Richter T, Schardey HM, Wittmann F, Mayr S,
Schmitt-Sody M, Blasenbreu S, et al. Rifampin and Triclosan
but not silver is effective in preventing bacterial infection of
vascular dacron graft material. Eur J Vasc Endovasc Surg
2003;26:550-7.
- Fysaraki M, Samonis G, Valachis A, Daphnis E,
Karageorgopoulos DE, Falagas ME, et al. Incidence, clinical,
microbiological features and outcome of bloodstream
infections in patients undergoing hemodialysis. Int J Med
Sci 2013;10:1632-8.
- Murphy EH, Szeto WY, Herdrich BJ, Jackson BM, Wang GJ,
Bavaria JE, et al. The management of endograft infections
following endovascular thoracic and abdominal aneurysm
repair. J Vasc Surg 2013;58:1179-85.
- Pajarinen J, Lin T, Gibon E, Kohno Y, Maruyama M, Nathan
K, et al. Mesenchymal stem cell-macrophage crosstalk and
bone healing. Biomaterials. 2018 Jan 2.
- Gong L, Zhao Y, Zhang Y, Ruan Z. The Macrophage
Polarization Regulates MSC Osteoblast Differentiation in
vitro. Ann Clin Lab Sci 2016;46:65-71.
- Maranda EL, Rodriguez-Menocal L, Badiavas EV. Role of
Mesenchymal Stem Cells in Dermal Repair in Burns and
Diabetic Wounds. Curr Stem Cell Res Ther 2017;12:61-70.
- Turksen K, editor. Wound Healing: Stem Cells Repair and
Restorations, Basic and Clinical Aspects. Hoboken, NJ: John
Wiley & Sons; 2017. p. 44-52.
- Manner S, Goeres DM, Skogman M, Vuorela P, Fallarero
A. Prevention of Staphylococcus aureus biofilm formation
by antibiotics in 96-Microtiter Well Plates and Drip Flow
Reactors: critical factors influencing outcomes. Sci Rep
2017;7:43854.
- Bozoglan O, Mese B, Eroglu E, Elveren S, Gul M, Celik
A, et al. Which prosthesis is more resistant to vascular
graft infection: polytetrafluoroethylene or Omniflow II
biosynthetic grafts? Surg Today 2016;46:363-70.
- Wozniak W, Kozinska A, Ciostek P, Sitkiewicz I.
Susceptibility of Vascular Implants to Colonization in vitro
by Staphylococcus aureus, Staphylococcus epidermidis,
Enterococcus faecalis and Pseudomonas aeruginosa. Pol J
Microbiol 2017;66:125-9.
- Meisel R, Brockers S, Heseler K, Degistirici O, Bülle
H, Woite C, et al. Human but not murine multipotent
mesenchymal stromal cells exhibit broad-spectrum
antimicrobial effector function mediated by indoleamine
2,3-dioxygenase. Leukemia 2011;25:648-54.
- Guerra AD, Cantu DA, Vecchi JT, Rose WE, Hematti P,
Kao WJ. Mesenchymal Stromal/Stem Cell and MinocyclineLoaded
Hydrogels Inhibit the Growth of Staphylococcus
aureus that Evades Immunomodulation of Blood-Derived
Leukocytes. AAPS J 2015;17:620-30.
- Uccelli A, de Rosbo NK. The immunomodulatory function
of mesenchymal stem cells: mode of action and pathways.
Ann N Y Acad Sci 2015;1351:114-26.
- Qian J, Hu Y, Zhao L, Xia J, Li C, Shi L, et al. Protective Role
of Adipose-Derived Stem Cells in Staphylococcus aureusInduced
Lung Injury is Mediated by RegIIIg Secretion. Stem
Cells 2016;34:1947-56.